A novel phenylpyridazinone, T-3999, reduces the progression of autoimmune myocarditis to dilated cardiomyopathy

FA Kamal, K Watanabe, M Ma, Y Abe, R ElBarbary… - Heart and vessels, 2011 - Springer
Regardless of the origin, injury to the heart can result in cardiomyocyte hypertrophy, fibrosis,
and cell death. Myocarditis often progresses to dilated cardiomyopathy (DCM), a major …

Mast cell inhibition attenuates myocardial damage, adverse remodeling, and dysfunction during fulminant myocarditis in the rat

Y Mina, S Rinkevich-Shop, E Konen… - Journal of …, 2013 - journals.sagepub.com
Background: Myocarditis is a life-threatening heart disease characterized by myocardial
inflammation, necrosis, and chronic fibrosis. While mast cell inhibition has been suggested …

Regulation of inflammation and myocardial fibrosis in experimental autoimmune myocarditis

K Watanabe, V Sukumaran… - … & Allergy-Drug …, 2011 - ingentaconnect.com
Autoimmune responses and inflammation are involved in the pathogenesis of many
cardiovascular diseases. There is compelling evidence that inflammatory mechanisms may …

Chronic myocarditis induced by T cells reactive to a single cardiac myosin peptide: persistent inflammation, cardiac dilatation, myocardial scarring and continuous …

NR Ratcliffe, J Hutchins, B Barry, WF Hickey - Journal of autoimmunity, 2000 - Elsevier
Recent recognition that an autoimmune myocarditis may precede, and result in, dilated
cardiomyopathy has focused attention on immune mechanisms of myocardial injury. In this …

Phosphoinositide 3-kinase inhibitor LY294002 ameliorates the severity of myosin-induced myocarditis in mice

HS Liu, J Zhang, JL Guo, CY Lin, ZW Wang - Current Research in …, 2016 - Elsevier
Background Myocarditis, characterized by myocyte necrosis, fibrosis, and degeneration with
mononuclear cell infiltration, always causes heart failure in patients. Phosphoinositide 3 …

Natural evolution of cardiac function, cardiac pathology and antimyosin scan in a murine myocarditis model

C Kishimoto, GL Hung, M Ishibashi, BA Khaw… - Journal of the American …, 1991 - Elsevier
Serial technetium-99m radionuclide ventriculograms, indium-111 antimyosin antibody scans
and tissue biodistribution studies were performed in C, H/He mice with experimentally …

Alterations in cardiac function and gene expression during autoimmune myocarditis in mice

LB Stull, NA DiIulio, M Yu, CF McTiernan… - Journal of Molecular and …, 2000 - Elsevier
LB Stull, NA DiIulio, M. Yu, CF McTiernan, NB Ratliff, VK Tuohy and C. Schomisch Moravec.
Alterations in Cardiac Function and Gene Expression during Autoimmune Myocarditis in …

Early treatment with clarithromycin attenuates rat autoimmune myocarditis via inhibition of matrix metalloproteinase activity

K Hishikari, R Watanabe, M Ogawa, J Suzuki… - Heart, 2010 - heart.bmj.com
Background Matrix metalloproteinase (MMP) activity is upregulated in the hearts with
myocarditis, and its activation contributes to the changes in left ventricular function. A major …

Turning point in myocarditis

MW Cunningham - Circulation research, 2009 - Am Heart Assoc
Myocarditis is an acute inflammatory disease of the heart and a precursor of dilated
cardiomyopathy. 1–8 Myocarditis is often characterized by a cellular infiltrate, and if …

[HTML][HTML] Thalidomide and a dipeptidyl peptidase 4 inhibitor in a rat model of experimental autoimmune myocarditis

KJ Kim, JB Park, SP Lee, HK Kim… - Korean Circulation …, 2023 - ncbi.nlm.nih.gov
ABSTRACT Background and Objectives: Myocarditis is a potentially fatal disease, but
curative treatments have not yet been established. Myocardial inflammation is an important …